Literature DB >> 33704690

Antibacterial activity of selected invertebrate species.

Salwa Mansur Ali1, Ruqaiyayh Siddiqui2, Kuppusamy A Sagathevan1, Naveed Ahmed Khan3,4.   

Abstract

The evolution of multiple-drug resistant bacteria is contributing to the global antimicrobial crisis, hence driving us to search for novel antimicrobial(s). Among animals, invertebrates represent up to 80% of all known species suggesting their wide distribution. Despite their ubiquitous and plentiful nature, they have been largely unexplored as potential source of antibacterials. In this study, we selected a broad range of invertebrates from terrestrial and marine environments and tested their lysates for antibacterial activity against methicillin-resistant Staphylococcus aereus (MRSA) and neuropathogenic Escherichia coli K1. Cockroaches, centipedes, tarantulas, prawns, lobster, and mud crabs showed antibacterial activity with selected lysates exhibiting more than 90% bactericidal effects. The red-headed centipede's hemolymph showed 90% and 50% bacteriostatic activity against MRSA and E. coli K1, respectively. Tarantula's body extracts exhibited antibacterial activity against MRSA and E. coli K1. Gut extracts of tiger prawn exhibited more than 90% bacteriostatic activity against both bacteria. The selected lobster and mud crab extract exhibited up to 90% growth inhibitory activity against MRSA. Overall, these results showed that selected invertebrates are an untapped source of broad-spectrum antibacterial activity and suggest the presence of biologically active molecules.

Entities:  

Keywords:  Antibacterial; Drug resistant bacteria; Insects; Invertebrates

Year:  2021        PMID: 33704690     DOI: 10.1007/s12223-021-00860-6

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  20 in total

1.  Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae).

Authors:  S Haeberli; L Kuhn-Nentwig; J Schaller; W Nentwig
Journal:  Toxicon       Date:  2000-03       Impact factor: 3.033

Review 2.  Potential synergism of natural products in the treatment of cancer.

Authors:  S HemaIswarya; Mukesh Doble
Journal:  Phytother Res       Date:  2006-04       Impact factor: 5.878

Review 3.  Natural products to drugs: natural product-derived compounds in clinical trials.

Authors:  Mark S Butler
Journal:  Nat Prod Rep       Date:  2008-05-07       Impact factor: 13.423

4.  Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).

Authors:  Salwa Mansur Ali; Ruqaiyyah Siddiqui; Seng-Kai Ong; Muhammad Raza Shah; Ayaz Anwar; Peter J Heard; Naveed Ahmed Khan
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-14       Impact factor: 4.813

5.  Gut bacteria of cockroaches are a potential source of antibacterial compound(s).

Authors:  N Akbar; R Siddiqui; M Iqbal; K Sagathevan; N A Khan
Journal:  Lett Appl Microbiol       Date:  2018-03-25       Impact factor: 2.858

Review 6.  Insects, arachnids and centipedes venom: A powerful weapon against bacteria. A literature review.

Authors:  Filippo Fratini; Giovanni Cilia; Barbara Turchi; Antonio Felicioli
Journal:  Toxicon       Date:  2017-02-24       Impact factor: 3.033

Review 7.  Animals living in polluted environments are a potential source of anti-tumor molecule(s).

Authors:  Shareni Jeyamogan; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  Cancer Chemother Pharmacol       Date:  2017-08-09       Impact factor: 3.333

8.  Antibacterial activities in various tissues of the horse mussel, Modiolus modiolus.

Authors:  Tor Haug; Klara Stensvåg; Ørjan M Olsen M; Erling Sandsdalen; Olaf B Styrvold
Journal:  J Invertebr Pathol       Date:  2004-02       Impact factor: 2.841

9.  Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.

Authors:  Anthony S Fauci; Nancy A Touchette; Gregory K Folkers
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

10.  Natural health products, modulation of immune function and prevention of chronic diseases.

Authors:  Pierre S Haddad; Georges A Azar; Simon Groom; Michel Boivin
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.